Clinical Trials · NCT00466856

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

TerminatedPhase 2Octreotide (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
Vanderbilt-Ingram Cancer Center
Enrollment
10
Start date
Dec 2003
Locations
1 site, United States
Primary endpoint
Tumor response
View Octreotide compound reference